CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Breast Neoplasms [Disease/Finding] Drug Hypersensitivity [Disease/Finding] trastuzumab [Chemical/Ingredient] Increased Cellular Death [PE] Increased Protein Breakdown [PE] T [Preparations] HER2/Neu/cerbB2 Antagonists [MoA] TRASTUZUMAB http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2#nlm34084-4 C0728747 Ingredient TRASTUZUMAB Active trastuzumab N0000148593 P188ANX8CK <VANDF_Record>50.6^3536^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3536</VA_IEN> 4021140 <VANDF_Record>50.416^3812^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3812</VA_IEN> 224905 C21052 breast cancer dyspnea AE nasopharyngitis AE rhinitis AE tachycardia AE fever AE rash AE infection AE pain AE headache AE asthenia AE arthralgia AE dizziness AE edema limbs AE paresthesia AE chills AE anorexia AE cough AE flu syndrome AE abdominal pain AE back pain AE urinary tract infection AE depression AE bone pain AE edema AE sinusitis AE nausea AE vomiting AE diarrhea AE cardiac failure congestive AE accidental injury AE insomnia AE cough increased AE